Extension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans

NCT01273207 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

NIH

Sponsor class

Conditions

Bronchiolitis Obliterans
Constructive Bronchiolitis
Graft Versus Host Disease
Bronchiolitis, Exudative
Bronchiolitis, Proliferative
Graft-Versus-Host Disease

Interventions

DRUG: Cyclosporine Inhalation Solution (CIS)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)